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Abstract  
MTF1 is a conserved metal-binding transcription factor in eukaryotes that binds to 
conserved DNA sequence motifs, termed metal response elements (MREs). MTF1 responds 
to metal excess and deprivation, protects cells from oxidative and hypoxic stresses, and is 
required for embryonic development in vertebrates. We used multiple strategies to identify an 
unappreciated role for MTF1 and copper (Cu) in cell differentiation. Upon initiation of 
myogenesis from primary myoblasts, MTF1 expression increased, as did nuclear localization. 
Mtf1 knockdown impaired differentiation, while addition of non-toxic concentrations of Cu
+
 
enhanced MTF1 expression and promoted myogenesis. Cu
+
 bound stoichiometrically to a C-
terminus tetra-cysteine of MTF1. MTF1 bound to chromatin at the promoter regions of 
myogenic genes and binding was stimulated by copper. MTF1 formed a complex with MyoD 
at myogenic promoters, the master transcriptional regulator of the myogenic lineage. These 
studies establish novel mechanisms by which copper and MTF1 regulate gene expression in 
myoblast differentiation. 
Introduction 
Copper (Cu) is an essential micronutrient required for human development and 
function. Cu plays a role in several key cellular functions, such as respiration, antioxidant 
defense, neurotransmitter biogenesis, disproportionation of O
-
, and metal ion homeostasis [1-
3]. Dysregulation of cellular Cu levels is detrimental to human health, and it is associated 
with redox stress, disruption of iron-sulfur cluster proteins, lipid peroxidation, and DNA 
oxidation [4]. Consequently, cells must control Cu levels and prevent the accumulation of 
labile Cu in the cytosol. Cu homeostasis is maintained by a complex cellular network of 
transmembrane transport systems, soluble chaperones, chelating proteins, and transcription 
factors (TFs) [3, 5-8]. Cu depletion or overload leads to pathological conditions, such as 
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Menkes’ disease and Wilson’s disease [8-15]. Menkes’ disease is characterized by severe Cu 
deficiency due to mutations in the Cu
+
-ATPase ATP7A that disrupt dietary Cu absorption. 
These inactivating mutations result in neurological abnormalities, blood vessel and 
connective tissue defects, and weak muscle tone (hypotonia) [16-20]. Wilson’s disease, 
which arises from mutations in the Cu
+
-ATPase ATP7B, results in Cu accumulation in the 
liver, brain, and eyes [19, 21, 22]. This Cu overload leads to a variety of hepatic and 
neurological defects, cardiomyopathies, and muscular abnormalities, such as a lack in 
coordination (ataxia) and repetitive movements (dystonia) [23, 24].  
Copper is a fundamental co-factor for several enzymes, including cytochrome c 
oxidase (COX), and superoxide dismutases (SOD1 and SOD3) [1, 2]. Cu is also an important 
component of enzymes that contribute to proper tissue function [25-28]. Myogenesis 
encompasses several metabolic and morphological changes that are linked to Cu
+
-dependent 
cellular energy production and redox homeostasis [1, 2]. During myoblast differentiation, a 
metabolic shift occurs in which energy is produced via oxidative phosphorylation [29, 30]. 
This metabolic shift involves an increase in the production of mitochondria and associated 
cuproenzymes essential for energy production (e.g. COX) and redox homeostasis (e.g. SOD1) 
[1, 2, 30, 31]. Dysfunction or inhibition of mitochondrial protein synthesis impairs 
myogenesis [32-35].  
We recently demonstrated that copper is required for the proliferation and 
differentiation of primary myoblasts derived from mouse satellite cells, which are adult stem 
cells responsible for skeletal muscle growth and repair from injury [36]. During myogenesis, 
the cellular levels of Cu increased, which is consistent with a high demand for Cu for proper 
function of mature tissue [36]. These changes in Cu levels are dependent on the dynamic 
expression of the Cu
+
-transporters and the post-transcriptional regulation of Atp7a [36]. 
However, the mechanisms by which Cu elicits a differentiation effect are unknown. Here, we 
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hypothesized that Cu may have a fundamental role in the regulation of gene expression that 
drives the differentiation of the skeletal muscle. Activation of the myogenic program at the 
transcriptional level requires a series of signals, including growth factors, TFs, kinases, 
chromatin remodelers, histone modifiers, and metal ions [36-52]. Emerging evidence 
suggests that Cu and potential Cu
+
-binding TFs play significant roles in mammalian 
development [53-56]. Despite this, only three Cu
+
-binding factors are known to regulate gene 
expression in mammalian cells, and little is known about their roles in developmental 
processes [53, 54, 57-66].  
Among these, MTF1 is a highly conserved zinc (Zn)-binding TF that recognizes and 
binds metal responsive elements (MREs) to promote the transcription of genes that maintain 
metal homeostasis [57, 59, 61, 67-70]. MREs are characterized by the -TGCRCNC- 
consensus sequence located near the promoters of genes related to redox and metal 
homeostasis [71-73]. MTF1 transcriptional activity is associated with the availability of Zn 
ions [74]; however, the molecular mechanisms by which metals activate MTF1 remain 
unclear. Current models for MTF1 activation include: (A) stimulation by free cytosolic Zn; 
(B) interaction with Zn released from metallothioneins (MTs); or (C) MTF1 
phosphorylation/dephosphorylation [73, 75-78]. Under normal conditions, MTF1 is primarily 
located in the cytoplasm. When MTF1 is activated, it translocates from the cytoplasm to the 
nucleus, where it recognizes and interacts with MREs of genes that mediate homeostasis [61, 
67, 79-84]. Chromatin immunoprecipitation (ChIP) analysis of Drosophila MTF1 has shown 
that different metal stimuli result in variations in the recognition of single nucleotides in 
genomic DNA sequences, showing that binding specificity can be altered by the presence of 
different metals [85]. Drosophila MTF1 has a Cu
+
 sensing function that is mediated in part 
by a carboxy-terminal tetra-nuclear Cu
+
 cluster [86]. A similar Cu
+
-binding centre has been 
identified in mammalian MTF1, suggesting that it may also respond to Cu [86]. Whether this 
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response is associated with maintenance of metal homeostasis, or if it is related to other 
cellular functions, remains to be elucidated. 
We have found that MTF1 is induced and translocated to the nucleus upon initiation 
of myogenesis in primary myoblasts derived from mouse satellite cells. shRNA and 
CRISPR/Cas9-mediated depletion of Mtf1 causes lethality of differentiating myoblasts, 
indicating that MTF1 is essential for myogenesis. Nuclear levels of Cu increase in 
differentiating primary myoblasts and significantly decrease upon partial deletion of Mtf1. In 
vitro characterization of the murine MTF1 carboxy-terminal binding domain determined it 
bound stoichiometrically to Cu
+
. ChIP-seq and qPCR analyses revealed novel MTF1 target 
genes that are associated with myogenesis in addition to classic metal homeostasis genes. 
MTF1 interaction with myogenic genes is enhanced by supplementation of non-toxic 
concentrations of Cu to the myoblast differentiation media. Finally, our data indicate that one 
potential mechanism by which MTF1 participates in the transcriptional regulation of 
myogenic genes is through an interaction with MyoD. Taken together, our results shed light 
on the under-appreciated role of Cu and Cu-binding TFs in the development of skeletal 
muscle.  
Results 
MTF1 is up-regulated during differentiation of primary myoblasts 
MTF1 is a metal binding transcription factor that is primarily involved in the control 
of metal and redox homeostasis [57, 59, 61, 67, 69, 70, 82, 83, 85, 87-91]. There is also 
evidence to suggest that MTF1 is involved in developmental processes [58, 62, 64, 92]. We 
hypothesized that MTF1 may play an active role in the determination of the myogenic lineage. 
To test this, we analysed both the expression and localization of MTF1 in primary myoblasts 
derived from mouse satellite cells. Western blot analyses showed minimal expression of the 
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MTF1 protein in proliferating primary myoblasts (Fig. 1A, B). However, MTF1 protein 
expression was upregulated when differentiation was induced, as shown by the expression of 
myogenic markers (Fig. 1A). Confocal microscopy imaging of MTF1 is consistent with 
western blot analyses (Fig. 1B). Proliferating primary myoblasts have low levels of MTF1 in 
a punctate cytosolic distribution. Upon induction of myogenic differentiation, MTF1 
expression increased and was primarily localized to the nucleus. At 48 and 72 h after 
initiation of differentiation, the distribution of MTF1 was primarily nuclear, though there was 
an increase in the cytosolic puncta that is consistent with its role in metal sensing. The data 
indicate that differentiation induces MTF1 expression and nuclear localization. 
Mtf1 is required for myoblast differentiation.  
To determine the physiological role of MTF1, we used viral vectors encoding small 
hairpin RNAs (shRNA) to knock down Mtf1, and the CRISPR/Cas9 system to generate Mtf1-
deficient primary myoblasts. Two lentiviral constructs that encode for shRNAs against Mtf1 
mRNA were used to knock down the endogenous protein in proliferating and differentiating 
primary myoblasts. Myoblasts transduced with a lentivirus-encoded non-specific scramble 
shRNA were used as negative controls. The virus-infected cells were selected with 
puromycin and the levels of Mtf1 were examined by Western blot analysis (Fig. 2). 
Differentiating myoblasts transduced with Mtf1 shRNA showed a decrease in the expression 
of MTF1 protein compared to wild type and scr shRNA controls (Fig. 2A). Mtf1 knockdown 
cells had similar growth kinetics compared to wild type cells, suggesting that proliferating 
primary myoblasts can tolerate MTF1 knockdown (Fig. 2B). These results suggests that the 
primary role of MTF1 in proliferating myoblasts is maintenance or metal homeostasis as 
opposed to regulation of the cell cycle. To determine whether the partial loss of MTF1 
impaired myogenesis, Mtf1 shRNA-transduced primary myoblasts were induced to 
differentiate. Western blot analyses for the differentiation marker sarco/endoplasmic 
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reticulum Ca
2+
-ATPase (SERCA) showed decreased levels in myoblasts partially depleted of 
MTF1 (Fig. 2A). Immunohistochemistry (IHC) analyses where differentiating myoblasts 
were stained with an anti-myogenin antibody confirmed that Mtf1 knockdown cells fail to 
differentiate, as they had a decreased incidence of myogenin-positive nuclei compared to 
wild type and scr shRNA transduced myoblasts (Fig. 2C). Detachment of Mtf1 knockdown 
cells was observed upon induction of differentiation (Fig. 2C). Western blot analyses showed 
an increased expression and activation of the apoptotic marker Caspase 3 in differentiating 
myoblasts partially depleted of Mtf1 (Fig. 2A).  
The biological relevance of MTF1 during myogenesis was confirmed by targeting the 
Mtf1 locus with CRISPR/Cas9. Western blot analyses of differentiating primary myoblasts at 
24 h showed over a 90% reduction in MTF1 protein and gene levels (Fig. S1). Consistent 
with our observations using shRNA (Fig. 2), MTF1 loss correlated with a failure to 
differentiate as shown by the decrease in protein and gene expression of myogenic markers 
(Fig. S1A-B). Mtf1-deficient cells proliferated normally and showed no visible phenotype 
during initial passages (Fig. S1C), however extended culture (5 passages) of these cells 
resulted in increased apoptosis relative to control cells (data not shown), suggesting that the 
MTF1-deficient cells are sensitive to extended passage in tissue culture. IHC analysis showed 
that Mtf1-deficient cells detached from the plates at 24 h after induction of myogenesis (Fig. 
S1D), which correlates with increased cleaved Caspase-3 (Casp3), as compared to wild type 
and empty vector sgRNA myoblasts (Fig. S1A). Overall, these results show that MTF1 plays 
an essential functional role in the regulation of the expression of myogenic genes and 
contributes to cell survival upon initiation of myogenic differentiation. 
MTF1 expression is enhanced by Cu ions 
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In order to induce myogenesis in cultured myoblasts, growth factors are depleted by 
serum starvation and insulin is added [93, 94]. Depletion of insulin from the differentiation 
medium partially prevents myogenic differentiation, a phenotype that we have recently 
shown can be rescued by the addition of non-toxic (30 µM) concentrations of CuSO4 [36]. 
Moreover, depletion of Cu from the culture medium inhibits differentiation, which suggests 
that Cu plays a role in differentiation [36]. However, the molecular mechanisms by which Cu 
affects differentiation are largely unknown. To probe for links between Cu ions and MTF1, 
we cultured primary myoblasts under different concentrations of Cu and determined the 
expression levels of MTF1 through Western blot and qPCR. Figure 3 shows that MTF1 
expression was significantly increased in cells grown in medium depleted of insulin and 
supplemented with 30 µM CuSO4 compared to those grown in basal differentiation medium 
containing insulin. By contrast, Cu chelation with tetraethylenepentamine (TEPA) resulted in 
a significant decrease in MTF1 expression. Addition of CuSO4 at a concentration equal to 
that of TEPA restored the expression levels of MTF1 to those observed in cells differentiated 
under normal insulin conditions. These data indicate a role for Cu ions in MTF1 induction 
during myogenesis. Importantly, we detected an increase in the expression of the 
differentiation marker SERCA when the cells were treated with Cu, which was abolished 
when the cells were depleted of Cu by addition of TEPA (Fig. 3A). These data are consistent 
with our previous studies where the expression of myogenin and other differentiation markers 
was enhanced by copper supplementation [36].  
MTF1 binds to the promoters of myogenic genes in differentiating myoblasts 
Our data thus far indicate that MTF1 is required for myogenesis in addition to its role 
in maintaining metal homeostasis. We hypothesized that copper enhances the transcriptional 
activity of MTF1, and that MTF1 globally regulates the expression of genes required for 
skeletal muscle differentiation. To test this, we performed ChIP-seq to identify MTF1 binding 
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sites on chromatin in primary myoblasts differentiated for 24 h under normal insulin 
conditions. Genome wide analyses showed that in the presence of insulin, MTF1 localized 
largely to promoters around transcriptional start sites (TSS; Fig. 4A). MTF1 binding to TSS 
was enhanced by the addition of CuSO4 to the culture media. Cells depleted of insulin from 
the culture media had decreased MTF1 binding that was similar to the input controls (Fig. 
4A). 
Next, we called peaks for MTF1 in differentiating myoblasts. We found 1399 MTF1 
peaks for myoblasts differentiated under normal insulin conditions, 2713 for cells 
differentiated in the presence of Cu, and only 553 peaks for the cells depleted of insulin. 
Strikingly, 993 peaks were shared between the cells differentiated with insulin and the cells 
differentiated with Cu (Fig. 4B, Table S1). Gene ontology (GO) analyses showed that MTF1 
binds to diverse categories of genes associated with muscle development, function and as 
expected, ion homeostasis (Fig. S2; Table S2).  
MTF1 is known to preferentially bind the MRE consensus sequence, -TGCRCNC- 
[71-73]. As expected, ChIP-seq analyses showed MTF1 enriched binding to this motif (Fig. 
4C, Table S1). In the presence of insulin or CuSO4, 32% and 38% of the MTF1 peaks 
contained a consensus MRE, respectively. This result suggests direct binding by MTF1 to 
MREs as one mechanism of MTF1-mediated gene activation, but also suggests that MTF1 is 
interacting with chromatin indirectly through other TF binding sites. We performed a de novo 
motif search on the Cu MTF1 peaks to identify additional binding motifs for MTF1. The 
regions under MTF1 peaks had high GC contents, and the top five motifs are shown (Fig. 4C, 
Table S1). The most significant of these motifs matches to the binding motif for the TF 
nuclear respiratory factor (NRF). NRF-1 and -2 play a role in the expression of nuclear and 
mitochondrial genes involved in oxidative phosphorylation, electron transport complexes I-V, 
and mtDNA transcription and replication [95, 96], all processes important in skeletal muscle 
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function. The second most significant motif matches the binding site of Sp1, a TF that has 
been shown to regulate muscle gene expression in concert with MyoD [97]. The next most 
significant motifs correspond to KLF3, SP5, and KLF9, each of which has been linked to 
skeletal muscle differentiation or function [98-101]. These data suggest that MTF1 may bind 
chromatin in conjunction with multiple diverse regulators to regulate gene expression during 
muscle differentiation. 
We found the conserved MRE sequence for MTF1 binding at some myogenic genes, 
such as Myogenin, which encodes the classic transcriptional activator that is expressed upon 
initiation of myogenesis and is essential for the transcription of muscle-specific genes [41, 48, 
102, 103]. Bioinformatic analyses revealed that two potential MREs, 5’-TGCACAG-3’ and 
5’-TGCACCC-3’, are located at 300 and 400 base pairs upstream, respectively, of the 
Myogenin TSS. Therefore, we hypothesized that MTF1 may bind near the promoter of 
Myogenin. To test this, we assessed our ChIP-seq data over the Myogenin promoter and 
found that MTF1 binding was enriched by Cu supplementation (Fig. 4D). The binding of 
MTF1 to Myogenin was validated by ChIP-qPCR, which showed a significant increase in 
binding when the myoblasts are differentiated in media supplemented with 30 µM CuSO4 
(Fig. 4E). 
Binding of MTF1 was evaluated at additional myogenic genes by ChIP-seq and ChIP-
qPCR. There is enhanced binding of MTF1 to the promoter of A Disintegrin And 
Metalloproteinase 9 (Adam9), a membrane anchored cell surface adhesion protein that 
mediates cell-cell and cell-matrix interactions and muscle development (Fig. S3A, B) [104]. 
MTF1 was also found at the promoters of additional myogenic genes, such as MyoD, Integrin 
7a, Skeletal actin, Myf5 and Cadherin 15 (Table S2). To validate our ChIP-seq analyses, we 
analyzed MTF1 binding to its classic target promoter, Metallothionein 1 (Mt1). ChIP-qPCR 
data showed that MTF1 binding to the Mt1 promoter is enhanced upon addition of 30 µM 
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CuSO4 to the culture media of primary myoblasts, as expected (Fig. S3C, D). As a negative 
control, no binding to the Pax7 promoter was observed (Fig. S4). 
MTF1 interacts with MyoD and binds a subset of MyoD-bound loci  
Interestingly, the classic DNA binding motif (E-box) of MyoD was included among 
the TF binding sites found within MTF1 peaks, suggesting a potential novel interaction at 
promoter regions for both transcription factors (Table S1, line 33). MyoD and MyoD-related 
factors initiate the regulation of skeletal muscle gene expression through direct binding of the 
promoters of myogenic genes during differentiation [97, 105]. We hypothesized that MTF1 
may interact with MyoD, forming a complex that binds the promoters of myogenic genes that 
MyoD regulates. We first investigated whether MTF1 and MyoD physically interact in 
primary myoblasts differentiated for 24 h. Immunoprecipitation (IP) assays using an anti-
MTF1 antibody revealed that MTF1 co-precipitated with MyoD upon initiation of 
myogenesis in both the presence and absence of Cu (Fig. 5A). To further characterize the 
functional relationship between MTF1 and MyoD, we compared the ChIP-seq datasets for 
MyoD in differentiated primary myoblasts (10 and 48 h) from Soleimani et al., [106] with 
our MTF1 ChIP-seq data. We found 714 peaks shared between MyoD and MTF1 when the 
myoblasts were differentiated in the presence of Cu, which represents over 25% of the total 
number of MTF1 peaks (Fig. 4B). GO term analyses of these peaks showed MyoD and 
MTF1 bind to myogenic genes, but also metal ion transport and homeostasis genes (Fig. S2, 
Table S3). De novo motif identification of overlapping MyoD and MTF1 peaks gives a 
similar outcome as the analysis of motifs under MTF1 peaks (Fig. 5C, 4C). Analysis of 
individual genes for MTF1 and MyoD binding showed increased peaks at the same promoter 
region of the Myogenin gene (Fig. 5D). This co-binding was confirmed by sequential re-ChIP 
analyses of MyoD and MTF1, which indicated that both TFs co-occupy the Myogenin 
promoter in myoblasts (Fig. 5E). We did not detect co-binding of the MTF1-MyoD complex 
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to the Pax7 promoter region (Fig. 5F), which further supports our conclusion that MTF1 
regulates differentiation-specific gene expression. Together, these data suggest that MyoD 
and MTF1 form a stable complex on chromatin in differentiating primary myoblasts to 
regulate the transcription of a common set of myogenic target genes. 
MTF1 binds Cu, which may play a role in its nuclear translocation and enhanced 
binding to myogenic promoters. 
We recently reported that differentiating myoblasts accumulate Cu, which is 
consistent with the inherent requirement for this metal during myogenesis [36]. Consistent 
with this hypothesis, atomic absorbance spectroscopy (AAS) analyses showed that the 
increase in Cu levels observed in differentiating myoblasts is prevented upon Cu chelation 
(Fig. S5A). Subcellular fractionation of proliferating and differentiating myoblasts showed 
that Cu is mobilized to the nucleus upon induction of myogenesis (Fig. S5B). Cells grown in 
the presence of Cu had higher levels of Cu in the nucleus than did control cells during 
proliferation. Lower levels of nuclear Cu were detected in myoblasts differentiated in the 
presence of TEPA (Fig. S5B). Cytosolic concentrations of Cu were higher than in the nucleus 
under all conditions tested (Fig. S5C).  
We hypothesized that the potential of MTF1 to bind copper may contribute to the 
nuclear translocation and enhanced activation of this TF. Interestingly, Drosophila MTF1 
contains a carboxy-terminal cysteine-rich Cu
+
-binding domain, distinct from its Zn finger 
domains that bind Zn ions, that is proposed to sense excess intracellular Cu and participate in 
the cellular heavy metal response [75, 86]. Mammalian MTF1 has a similar putative Cu
+
-
binding domain at its C-terminal domain. To test for a similar function, we cloned, expressed, 
and purified wild type murine recombinant MTF1 (Fig. 6A). We first examined the Cu
+
-
binding properties of the purified protein by incubating it with excess Cu
+ 
in the presence of 
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ascorbate as reducing agent. Metal determinations by AAS revealed that Cu
+
 interacts with 
MTF1 at a stoichiometry of 1.17 ± 0.06 Cu atoms per protein (Fig. 6B). To test whether Cu 
binds at the C-terminal cysteine-rich domain, we mutated the four key cysteine residues to 
alanines (metal binding site (MBS), Fig. 6A). These mutations strongly impaired the binding 
of Cu
+
 to MTF1 (Fig. 6B), implicating these amino acids in Cu
+
 binding. 
These data raise the possibility that MTF1 contributes to the translocation of Cu ions 
to the nucleus. To test this hypothesis, we took advantage of primary myoblasts partially 
depleted of Mtf1 by shRNA (Fig. 2). We evaluated whether MTF1 knockdown would impair 
the capability of the cells to translocate Cu into the nucleus. Overall, Mtf1 knockdown cells 
exhibited a significant decrease in the total levels of Cu upon induction of differentiation, 
whereas only a non-significant, but consistent small decrease in the levels of Cu in 
proliferating myoblasts was detected (Fig. 6C). Subcellular fractionation showed that Mtf1 
knockdown differentially affected the nuclear Cu content. For instance, proliferating Mtf1 
knockdown myoblasts contain only ~10% of nuclear Cu compared to wild type and scr 
controls. Nuclear fractions of differentiating Mtf1 knockdown cells contained ~50% of Cu 
compared to the control cells (Fig. 6D). Minor changes in the cytosolic levels of proliferating 
and differentiating Mtf1 knockdown myoblasts were detected (Fig. 6E).  These data are 
consistent with a role of MTF1 mobilizing Cu into the nucleus during myogenesis, but does 
not exclude the possibility that other proteins are also part of this process.  
 
Discussion 
There is a significant gap in our understanding of the roles that Cu plays in 
transcriptional regulation during mammalian development. Previous studies from our 
laboratory have shown that Cu promotes the proliferation and differentiation of primary 
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myoblasts derived from mouse satellite cells [36]. The pathways and mechanisms by which 
this transition metal induces this myogenic effect are largely unknown. In this work, we 
characterized the roles of copper and the Cu-binding transcription factor, MTF1, in 
myogenesis. Our data shows that MTF1 expression is essential for myogenesis, and that Cu 
enhances the expression of MTF1. Moreover, we have found that cellular Cu content 
influences the binding of MTF1 to target promoters. Finally, our studies revealed multiple 
mechanisms of MTF1 interaction at target genes, including direct binding to MREs and 
presumed indirect interactions through other transcription factors, including MyoD.  
MTF1 is activated by different mechanisms to control metal and redox homeostasis, 
which include stimulation by cytosolic Zn and/or Zn released from MTs, or regulation by 
phosphorylation events [73, 75-78]. On the other hand, the mechanisms by which MTF1 
stimulates transcription of metal responsive genes (MTs and metal transporters) in response 
to heavy metals and oxidative stress is well-established. A characteristic of the promoters and 
enhancers of most of MTF1 target genes is the presence of MREs in the upstream regulatory 
sequences or just downstream of the TSS of metal-responsive genes that mediate MTF1 
binding and regulation of gene expression [64, 71, 78, 83, 107].  
Activation of MTF1 by copper has been investigated in several vertebrate models. 
Studies have addressed the expression of MT1 as an indirect measure of MTF1 activity upon 
stress induced by copper and other metals. For instance, in vivo studies showing Cu-
dependent changes in the transcription of Mt1 in mouse liver showed that only high doses 
(over 5 mg/kg) of Cu administered to the animals induced the expression of this gene, while 
little effect of Cu was detected in the kidney [108]. Studies in HeLa S3 cells showed that the 
transcript levels of the metal protective MtIIA gene increased upon treatment with 300 µM 
CuSO4. However, in vitro studies using whole cell extracts obtained from HeLa S3 cells 
exposed to 300 µM CuSO4 failed to induce the MRE-binding activity, attributed to MTF1, 
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although this concentration of Cu was able to induce the expression of MtIIA [109]. In 
embryonic stem cells, induction of MT1 and MT2 was only achieved when the cells were 
treated with 500 µM CuSO4 [67]. It is noteworthy that studies from our laboratory showed 
that in differentiating, serum deprived, primary myoblasts derived from mouse satellite cells, 
concentrations over 100 µM are toxic to the cells [36]. The data presented here showed that 
supplementation of differentiating myoblast with 30 µM CuSO4, is sufficient to induce MTF1 
expression and activation, not only to drive the expression of metal-protective genes, but also 
to promote the expression of myogenic genes. Overall, the data suggests that the cellular 
metal response and activation of MTF1 is dependent on the cell lineage. Studies from 
different laboratories suggest that copper treatment is a poor activator of MTF1 in the context 
of its classic metal protective role, as shown by the expression of Mt1. However, the studies 
shown here suggest that low concentrations of Cu contribute to the activation of MTF1 in a 
novel role as a modulator of the expression of genes associated with myogenesis. Studies 
should be now directed to investigate the roles of MTF1 in the development of other lineages. 
Additional roles for MTF1 have been proposed during embryonic development [58]. 
MTF1 knockout leads to embryonic lethality at embryonic day 14 due to liver degeneration 
[58, 62]. The MTF1 target genes MT1 and MT2 are constitutively and highly expressed in 
fetal liver [110-112], suggesting that these proteins are fundamental for liver development. 
However, deletions of both metallothionein genes had no effect in development under normal 
conditions, but mice were sensitive to Cd stress [113, 114]. It is noteworthy that the MTF1 
knockout murine model had no evidence of muscular phenotypes in developing embryos at 
E14 [58]. These findings suggest that 1) MTF1 contributes but is not required for muscle 
development; 2) that MTF1 contributes to early muscle development but is only required for 
developmental stages at or after E14, or 3) that there is an as yet unidentified redundancy for 
the roles of MTF1 in myogenesis. We also note an intriguing link between MTF1, 
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Parkinson’s disease, and muscle function in Drosophila. Parkin is an E3 ubiquitin ligase 
mutated in some hereditary forms of Parkinson’s disease. The Drosophila homozygous 
mutant of the human ortholog parkin exhibits severe movement impairment, inability to fly, 
sterility, and short life span [92]. Overexpression of MTF1 in the parkin mutant flies partially 
rescues these phenotypes, likely due to an effect at the muscular and mitochondrial levels, 
supporting a role for MTF1 in muscle development [92]. In addition, myogenic regulatory 
factors such as MyoD, Myogenin, and the Myocyte Enhancer Factor 2 (MEF2) have been 
shown to regulate the expression of MTF1 in differentiating myoblasts, however no 
characterization has been done [115]. Therefore, the specific roles for MTF1 in development 
and in lineage determination remain to be elucidated. Our work suggests three potential 
mechanisms for MTF1 binding to myogenic genes: 1) Direct recognition and binding to 
MREs; 2) indirect binding through additional transcription factor binding sites; and 3) 
indirect binding through MyoD binding sites.  
Studies in Drosophila MTF1 described a novel carboxy-terminal tetra-nuclear Cu center, 
independent of the Zn binding fingers [86]. Functional studies of the mammalian MTF1 
showed a carboxy-terminal 13 amino acid domain that includes four conserved cysteines 
(CQCQCAC) that are necessary for MTF1 Zn and Cd sensing and transcriptional activation 
in vivo under  moderate  metal  stress [116, 117]. Interestingly, these Drosophila and 
mammalian cysteine domains lack significant sequence homology and have been proposed to 
be the result of convergent evolution events of a Cu sensing element [86].  This cysteine 
cluster also mediates the homo-dimerization of MTF1, which is proposed to constitute a 
platform for the recruitment of additional transcriptional cofactors [118]. In this regard, Cu 
has been proposed to play a relevant role in stabilizing the dimer by constituting 
intermolecular disulphide bonds through oxidation of cysteines to further synergize with zinc 
to enhance transcription [118]. However, the mechanistic role of this domain in regulation of 
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metal homeostasis and development genes is not yet clear. Importantly, our data corroborates 
that Cu is internalized during myoblast differentiation and a fraction of the internalized Cu is 
re-localized to the nuclei. Considering the significant increase in MTF1 expression upon 
addition of Cu and the Cu-binding capabilities of the carboxy-terminal cysteine cluster of 
MTF1, it is plausible that MTF1 is partially responsible for the nuclear translocation of 
copper observed in differentiating myoblasts. Studies are under way to further characterize 
the mechanistic roles of this novel Cu-binding domain in the regulation of gene expression 
associated with the myogenic lineage, metal and redox homeostasis, as well as the potential 
interactions between MTF1 and additional metal-dependent protein-protein interactions at 
MREs in promoter regions. 
Current investigations in the field have been directed towards understanding the 
deleterious effects of Cu on the nervous system, liver, and intestine. However, little attention 
has been given to other organs and tissues, such as muscle, adipose, and bone. Strikingly, 
most of the systemic phenotypes observed in Menkes’ and Wilson’s disease patients have 
been attributed to the neurological damage that Cu exerts as a result from deficient systemic 
transport, rather than a direct effect on the different tissues and organs. However, a complex 
developmental process such as myogenesis encompasses metabolic and morphological 
changes linked to Cu-dependent energy production and redox homeostasis [1, 2]. Myoblast 
differentiation requires a metabolic shift in which energy is produced via oxidative 
phosphorylation, a process highly dependent on increased production of mitochondria, Cu 
availability and expression of cuproenzymes essential for energy production (e.g. COX) and 
redox homeostasis (e.g. SOD1) [1, 2, 30, 31]. Our results shed light onto the importance of 
the function of Cu and MTF1 in the regulation of gene expression during developmental 
processes, such as skeletal muscle differentiation. A better understanding of how tissue Cu 
status affects growth and development at other cellular levels, will be beneficial in the study 
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of muscular phenotypes that present in diseases of Cu misbalance, such as Menkes’ and 
Wilson’s diseases. 
Material and methods 
Primary Cell Culture  
Mouse satellite cells were isolated from leg muscle of 3-6 week old wild type 
C57Bl/6 mice. The muscle was extracted and cut into small pieces, washed with Hank’s 
Balanced Salt Solution (HBSS; ThermoFisher Scientific) and incubated with 0.1% Pronase 
for 1 h at 37 ºC. The cells were then filtered using a 100 μm cell sieve and resuspended in 3 
ml of growth media (1:1 v/v DMEM:F-12, 20% FBS, and 25 ng/ml of basic FGF). Cells were 
filtered again using a 40 µm cell sieve and centrifuged at 1,000 x g for 1 min at room 
temperature. The cells were placed at the top of a Percoll step-gradient (35 and 70%) and 
centrifuged 20 min at 1,850 x g at room temperature. The myoblasts were contained in the 
lower interface of the 70% Percoll fraction and were washed with HBSS, centrifuged 5 min at 
1,000 x g, and resuspended in growth media for plating. Myoblasts were grown and 
differentiated on plates coated with 0.02% collagen (Advanced BioMatrix) [119]. The 
different treatments (indicated in the figures) were: proliferation and differentiation (24 h). 
Presence and absence of CuSO4 and/or Tetraethylenepentamine (TEPA); the concentrations 
used were 100 µM for proliferating cells and 30 µM for differentiating cells as previously 
described [36].  
Plasmid construction, virus production, and transduction of primary myoblasts 
For shRNA viral production, Mission plasmids (Sigma) encoding for two different 
shRNA against Mtf1 and a scramble (scr) are indicated in Table S4. CRISPR/Cas9 plasmid 
construction was performed by custom-designed of four sgRNAs to recognize the exon 1, 
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exon 2, exon 4 and exon 8 of MTF1 mouse gene (Reference Sequence: NM_008636.4). Each 
gRNA consisted of 20 nucleotides complementary to the sequence that precedes a 5′-NGG 
protospacer-adjacent motif (PAM) located in the targeted exon. Specificity was validated by 
search through the entire genome to avoid off-target effects. Preparation of CRISPR/Cas9 
lentiviral constructs was performed using the lentiCRISPRv2 oligo cloning protocol [120]. 
Briefly, sense and antisense oligos obtained from Integrated DNA technology (IDT), were set 
according to the designed gRNA and were annealed and phosphorylated to form double 
stranded oligos. Subsequently, they were cloned into the BsmBI–BsmBI sites downstream 
from the human U6 promoter of the lentiCRISPRv2 plasmid [120, 121] that was a kind gift 
from Dr. Feng Zhang (Addgene plasmid # 52961). The empty plasmid that expresses only 
Cas9 but no gRNA was included as null knock out control. The ligation reaction was used to 
transform competent Stbl3 bacteria, and positive cloning was confirmed by sequencing. 
Oligonucleotides used to form double stranded gRNAs are listed in Table S5. 
To generate Lentiviral particles, 5 X 10
6
 HEK293T cells were plated in 10 cm dishes. 
The next day, transfection was performed using 15 µg of each shRNA and the packing 
vectors pLP1 (15 µg), pLP2 (6 µg), pSVGV (3 µg). CRISPR/Cas9 lentiviral particles were 
generated using a mixture of 12 µg of each construct, 9 µg of psPAX2 and 3 µg of pVSV-G 
packaging vectors. Plasmid mistures were diluted in 3 ml OptiMEM (Life Technologies) and 
supplemented with 60 µl Lipofectamine 2000 (Invitrogen). The complete mixture was 
incubated for 15 min before being added to cells. After an overnight incubation, the media 
was changed to 10 ml DMEM (Life Technologies) with 10 % FBS (Life Technologies). The 
viral supernatant was harvested after 48 h of incubation and filtered through 0.45 µm syringe 
filter (Millipore). To infect primary myoblasts, 5 ml of the filtered supernatant supplemented 
with 8 µg/ml polybrene (Sigma) were used to infect two million cells for overnight. Infected 
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cells were then selected in DMEM/F12 (Life Technologies) containing 20% FBS, 0.75 ng/ml 
of Fibroblast Growth Factor and 1.5 µg/ml puromycin (Invitrogen). 
Antibodies 
Primary antibodies (used at 1:1000) were obtained from Santa Cruz Biotechnologies: 
rabbit anti-MTF1 (sc-365090), rabbit anti-PI3K (sc-515646), mouse anti-β-actin (sc-81178), 
mouse anti-SERCA (sc-271669). From Abclonal: rabbit anti-caspase 3 (A2156), rabbit anti-
MyoD; and a rabbit anti-GAPDH-HRP was from Sigma (G9295). Normal l Rabbit IgG was 
obtained from Cell signalling Technologies (2729). The anti-myosin heavy chain (MF20, 
deposited by D. A. Fischman), anti-myogenin antibody (F5D, deposited by W.E. Wright) was 
obtained as hybridoma supernatants from the Developmental Studies Hybridoma Bank 
(University of Iowa). The secondary antibodies used were: goat anti-rabbit and anti-mouse 
coupled to HRP (1:1000, Life Technologies).  
Primary myoblast immunofluorescence  
Primary myoblasts for immunofluorescence were grown on glass bottom Cellview 
Advanced TC culture dishes (Grenier Bio One). Samples were obtained for proliferation and 
at 24, 48 and 72 h after induction of differentiation. Cells were fixed in 10% formalin, 
permeabilized with PBT buffer (0.5% Triton-X100 in PBS) and blocked in 5% horse serum 
in PBT. Cells were incubated with the rabbit anti-MTF1 antibody (1:100) in blocking 
solution overnight at 4 ºC. The samples were then washed three times with PBT solution for 
10 min at room temperature. Then, the cells were incubated with the goat anti-rabbit Alexa-
488 secondary antibody (1:500) in blocking solution for 2 h at room temperature and 30 min 
with DAPI. Cells were counterstained with DAPI and imaged with a Leica TCS SP5 
Confocal Laser Scanning Microscope (Leica) using a 40X water immersion objective. 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/534271doi: bioRxiv preprint first posted online Jan. 29, 2019; 
21 
 
Immunohistochemistry 
Proliferating and differentiating primary myoblasts at the desired time points were fixed 
overnight in 10% formalin-PBS at 4 °C. Samples were washed with PBS and permeabilized 
for 10 min in PBS containing 0.2% Triton X-100. Immunohistochemistry was performed 
using universal ABC kit and developed with Vectastain Elite ABC HRP kit (Vector Labs) 
following manufacturer’s instructions.  
Gene expression analyses 
Three independent biological replicates of proliferating and differentiating (24 h) 
primary myoblasts were washed with ice cold PBS and RNA extracted using Trizol 
(Invitrogen). cDNA synthesis was performed using 1 μg of RNA, DNase I amplification 
grade (Invitrogen 18068-015) and Superscript III (Invitrogen 18080-400) according to 
manufacturer’s instructions. Changes in gene expression were analyzed by quantitative RT-
PCR using Fast SYBR-Green master mix (Thermofisher Scientific) on the ABI StepOne Plus 
Sequence Detection System (Applied Biosystems) using the comparative Ct method [122] 
using Ef1α as control. The primers are listed in Table S5. 
 Chromatin Immunoprecipitation (ChIP) Assays 
Three independent biological replicates of proliferating and differentiating (24 h) 
primary myoblasts were crosslinked with 1% Formaldehyde and incubated for 10 min at 
room temperature on an orbital shaker. To inactivate the formaldehyde, 1 ml of 1 M glycine 
was added and cells were incubated for 5 min on an orbital shaker at room temperature. Cells 
were washed 3 times with 10 ml of ice cold PBS supplemented with Complete Protease 
Inhibitor (Roche). Crosslinked myoblasts were resuspended in 1 ml of ice cold PBS 
supplemented with Complete Protease Inhibitor. The cell suspension was centrifuged for 5 
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min at 5,000 x g at 4 ºC. The PBS was removed and the cell pellet was resuspended in 200 µl 
of ice cold SDS lysis buffer (50 mM Tris pH 8; 10 mM EDTA, 1% SDS) for 10 min. 
Proliferating myoblasts were sonicated three times for 5 min, 30” by 30” at mild intensity for 
myoblasts and five times for nascent myotubes using a Bioruptor UCD-200 (Diagenode). The 
samples were diluted to a final volume of 1 ml in ChIP buffer (16 mM Tris pH 8.1; 1.2 mM 
EDTA; 0.01% SDS; 1.1% Triton X100; 167 mM NaCl). ChIP was performed using a rabbit 
anti-MTF1 and a rabbit IgG antibodies. Samples were incubated for 2 h at 4 ºC in a rotating 
platform and subsequently, 80 µl of Magna ChIP protein A+G Magnetic Beads (Millipore) 
were added to each sample and incubated overnight in a rotating platform at 4 ºC. The 
samples were then placed in a magnetic rack and sequentially washed using 1 ml each of the 
wash buffer sequence A-D (Buffer A: 20 mM Tris pH 8.1, 2 mM EDTA, 0.1% SDS, 1% 
Triton-X100, 167 NaCl, Buffer B: 20 mM Tris pH 8.1, 2 mM EDTA, 0.1% SDS, 1% Triton-
X100, 500 NaCl; Buffer C: 10 mM Tris pH 8.1, 1 mM EDTA, 1% NP40, 1% Sodium 
deoxicholate, 0.25 M LiCl2; Buffer D: 10 mM Tris pH 8.1, 1 mM EDTA). Immune 
complexes were eluted in 100 µl of buffer containing 0.1 M NaHCO3, 1% SDS, 1 µg/µl 
proteinase K. Samples were then reverse-crosslinked by adding 20 µl of 5 M NaCl and 
incubating overnight at 65 ºC. The reverse crosslinked DNA was purified using the ChIP 
DNA clean concentrator, following the manufacturer’s instructions (Zymo Research). The 
DNA was stored at -80 ºC until further analysis by semi-quantitative real time PCR or library 
preparation for ChIP-Seq. 
ChIP-seq 
Library construction - Libraries of ChIP-enriched DNA were prepared from two 
biological replicates following the Illumina strategy. Samples were end-repaired, A-tailed, 
and adaptor-ligated using barcoded inline adaptors according to the manufacturer’s 
instructions (Illumina). DNA was purified over a Zymo Research PCR purification column 
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between each enzymatic reaction. DNA was PCR amplified with KAPA HiFi polymerase 
using 16 cycles of PCR. Each library was size-selected for 200-300 bp fragments on a 1.5% 
agarose gel and the library concentrations were determined using a QuBit 3.0 Fluorometer 
(Thermo Scientific). Libraries were sequenced on an Illumina HiSeq2000 using single-end 50 
bp sequencing at the University of Massachusetts Medical School deep sequencing core 
facility. 
Data Analysis - Single-end fastq reads were split by barcode adapter sequences and 
adapter sequences were removed using the Fastx toolkit. Reads were mapped to the mm10 
genome using bowtie, allowing up to three mismatches. Aligned reads were processed using 
HOMER [123].  UCSC genome browser tracks were generated using the “makeUCSCfile” 
command”. Mapped reads were aligned over all annotated mm10 TSSs using the 
“annotatePeaks” command, generating 20 bp bins and summing the reads within each 
window. After anchoring mapped reads over reference TSSs, aggregation plots were 
generated by averaging data obtained from two biological replicates. Peaks were called 
individually from replicate datasets using the “findPeaks” command and then overlapping 
peaks were identified using the “mergePeaks” command. For peak calling, a false discovery 
rate (FDR) of 0.001 was used as a threshold. Motifs were identified using the “findMotifs” 
command.  
Analysis of data from GSE24852 [106] was performed similarly. Data was 
downloaded from GSE24852 and converted to fastq files using SRAtoolkit fastq-dump and 
mapped reads were converted to mm10. Aligned reads were processed in HOMER [123], as 
described above.   
Gene Ontology (GO) term identification – GO term analysis was performed on metascape 
http://metascape.org [124].  
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Sequential chromatin immunoprecipitation (Re-ChIP) 
Primary myoblasts were lysed using the SimpleChIP® Plus Sonication Chromatin IP 
Kit (Cell Signaling Technologies), following the manufacturer’s instructions. Briefly, after 
incubating the samples with MTF1 antibody and collecting immunoprecipitated material with 
magnetic beads, the samples were incubated with an equal volume of 10 mM dithiothreitol 
(DTT) for 30 min at 37 ºC [125-127]. The supernatant was used for the second 
immunoprecipitation by adding a rabbit anti-MyoD antibody and incubating the samples 
similarly to the first immunoprecipitation. IgG substituted for the MTF1 and MyoD 
antibodies served as a negative control. 
Western blot analysis 
Proliferating and differentiating primary myoblasts were washed with PBS and 
solubilized with RIPA buffer (10 mM PIPES, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% 
Triton X-100, 0.5% sodium deoxycholate, and 10% glycerol) containing Complete Protease 
Inhibitor. Protein was quantified by Bradford [128]. Samples (20 µg) were prepared for SDS-
PAGE by boiling in Laemmli buffer. The resolved proteins were electrotransferred to PVDF 
membranes (Bio-Rad). The proteins of interest were detected with the specific polyclonal or 
monoclonal antibodies. Then the membranes were incubated for 2 h at room temperature with 
the species-appropriate peroxidase-conjugated antibodies (Invitrogen). Chemiluminescent 
detection was performed with ECL PLUS (GE Healthcare). Experiments were performed 
using samples from three independent biological experiments. 
Immunoprecipitation 
Cells were washed three times with ice-cold PBS and resuspended in IP lysis buffer 
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 
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Complete Protease Inhibitor). Cell extracts were incubated with the anti-MTF1 primary 
antibody at 4 °C for 2 h, followed by an overnight incubation with PureProteome Protein A/G 
mix magnetic beads (Millipore). Samples were washed as indicated by the manufacturer, and 
immunoprecipitated proteins were eluted in freshly prepared IP-elution buffer (10% glycerol, 
50mM Tris HCl, pH 6.8, and 1 M NaCl) at room temperature for 1 h [42]. Samples were 
analyzed by SDS-PAGE and Western blot. 
Subcellular fractionation of primary myoblasts and metal content analysis  
Three independent biological replicates of proliferating and differentiating (24 h) 
primary myoblasts were fractionated using the Rapid Efficient And Practical (REAP) nuclear 
and cytoplasmic separation method [129]. Briefly, cells were washed with ice cold PBS, 
scraped and transferred to a 1.5 ml microcentrifuge tube. Samples were centrifuged for 10 
seconds at 13,000 x g and the supernatant was discarded. The samples were resuspended in 
500 µl of ice cold PBS containing 0.1% NP40 (Calbiochem) and 100 µl of the cell 
suspension were collected as the whole cell fraction. The remaining 400 µl were used to 
obtain nuclear and cytosolic fractions by disrupting the cells by pipetting using a 1 ml pipette 
tip. Cell suspension was centrifuged for another 10 sec and the supernatant was collected as 
the cytosolic fraction. The nuclear pellet was then washed twice in 1 ml of ice cold PBS 
containing 0.1% NP40 and once again centrifuged for additional 10 sec. The supernatant was 
removed and pellet was resuspended in 100 µl of PBS. Nuclear integrity was verified by light 
microscopy. All samples were sonicated at medium intensity for 5 min in 30 s on 30 s off 
cycles. Protein was quantified by Bradford method [128]. Purity of the fractions was 
evaluated by western blot.  
The comparative analysis of copper concentrations from each sample was carried out 
using an AAS equipped with a graphite furnace (PerkinElmer, AAnalyst 800). A known mass 
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of sample was acid digested in concentrated HNO3, using a single-stage digestion method 
[130, 131]. All measurements were performed in triplicate, resulting in a limit of detection 
for Cu of 15 ppb, calculated as 3σ. Analytical grade standards were used and diluted in 18 
MΩ purified water.  Copper content on each sample was normalized to the initial mass of 
protein. 
Expression and purification of recombinant MTF1 
MTF1 wild type pET-GST/TEV/mMtf1[NM_008636.4] plasmid was purchased from 
Vector Builder. This plasmid was used as a template to introduce the mutations coding for the 
multiple Alanine substitutions in the putative carboxy-terminus Cu
+
-binding site (MBS) using 
the oligos indicated in Table S5. Mutations were introduced using the quick change 
mutagenesis kit following the manufacturer’s instructions (Agilent Technology). The pET 
vector places a GST tag at the amino-terminus, which was used for purification of the 
recombinant proteins. DNA sequences were confirmed by automated sequencing. 
Plasmids coding for MTF1 wild type and the MBS mutant proteins were transformed 
into Stbl3 cells for propagation and transformed into BL21 DE3 bacteria for expression. 
Recombinant protein expression was performed according to an auto-inducing medium 
protocol [132]. Purification of GST-tagged wild type and mutated MTF1 recombinant 
proteins was carried out using Glutathione Agarose resin as described by the manufacturer 
(Pierce). Purified proteins were stored at -20 ºC in Buffer containing 10% glycerol, 100 mM 
Tris, pH 8, and 150 mM NaCl. Protein concentrations were determined by Bradford assay 
[128]. Molar protein concentrations were estimated using MW 81,000 Da for both MTF1 
proteins. In order to eliminate any bound metal, all purified proteins were treated with metal 
chelators as described previously [133-136]. Briefly, the proteins were incubated for 45 min 
at room temperature with 0.5 mM EDTA and 0.5 mM tetrathiomolybdate. Chelators were 
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removed by buffer exchange using either 50 kDa cut-off Centricons (Millipore). The final 
purity of all protein preparations was at least 95%, as verified by SDS-PAGE followed by 
Coomassie Brilliant Blue staining and Western blot. 
Cu Loading to MTF1 and metal binding analyses 
Cu
+
 loading was performed by incubating each apo-protein (10 µM) in the presence 
of 10 M excess of CuSO4, 25mM Hepes (pH 8.0), 150 mM NaCl and 10 mM ascorbate for 10 
min at room temperature with gentle agitation, as previously described [136]. The unbound 
Cu was removed by washing in 50 kDa cut-off Centricons. Levels of Cu bound were verified 
by AAS, Varian. Briefly, before determinations, sample aliquots were mineralized with 35% 
HNO3 (trace metal grade) for 1 h at 80 °C, and digestions were concluded by making the 
reaction 3% H2O2. Metal bound to wild type and mutant MTF1 was measured in triplicate 
using a method similar to the subcellular fractionation of primary myoblasts (vide supra). 
Statistical analyses 
 In all cases, the data represent the average of three independent biological replicates ± 
SE. Two-tailed t tests were performed for statistical analyses using Graphpad Prism, Version 
7 
Data availability 
Genomic datasets have been deposited within GEO.  
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Figures and figure legends  
Figure 1 
 
 
 
 
 
Figure 1. MTF1 is induced upon induction of differentiation of primary myoblasts. (A) 
Representative western blot of MTF1 expression; the myogenic differentiation markers 
examined were myosin heavy chain (MHC), and the sarco/endoplasmic reticulum Ca
2+
-
ATPase (SERCA) from proliferating and differentiating primary myoblasts at 24, 48 and 72 h. 
PI3K was used as loading control. (B) Representative confocal microscopy images of 
proliferating and differentiating primary myoblasts at 24, 48 and 72 h for MTF1 (green), and 
DAPI (blue). Images depicted are representative of at least three independent biological 
experiments. 
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Figure 2 
 
 
 
 
Figure 2. Partial depletion of MTF1 using shRNA impairs myogenesis and partially 
leads to death of differentiating myoblasts. (A) Representative Western blot of primary 
myoblasts and myoblasts transduced with either scramble shRNA (scr) or two different 
shRNAs against Mtf1 (1 and 2) during proliferation and 24 h after inducing differentiation. 
SERCA levels were monitored as a differentiation marker, cleaved Caspase 3 as marker of 
cell death, and PI3K as a loading control. (B) Proliferation curves comparing wild type, 
scramble control (scr), and MTF1 (shRNA 1 and 2) partially depleted primary myoblasts. No 
significant differences were found between the four strains. Data represent the average of 
three independent experiments ± SE. (C) Representative light micrographs of differentiating 
myoblasts immunostained for myogenin at 24 and 48 h.  
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Figure 3 
 
 
 
 
 
 
 
 
 
 
Figure 3. Copper enhances the expression of MTF1 in differentiating myoblasts. (A) 
Representative Western blots of MTF1 and SERCA in proliferating and differentiating 
myoblasts differentiated in the presence or absence of insulin, Cu and TEPA as indicated. 
GAPDH was used as loading control. (B) Densitometric quantification of MTF1 bands in 
proliferating and differentiating (24, 48 and 72 h) primary myoblasts. (C) Steady-state mRNA 
levels of Mtf1 determined by qRT-PCR from proliferating and differentiating primary 
myoblasts cultured in the same conditions described in (A). The data represent the average of 
three independent biological experiments ± SE; *P < 0.01. 
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Figure 4 
 
 
 
 
 
 
 
Figure 4. MTF1 binding in differentiating primary myoblasts. (A) Aggregation plots of 
MTF1 ChIP-Seq data showing occupancy over annotated TSS. (B) Overlap of ChIP-Seq 
peaks of MTF1 across the genome observed in differentiating cells in the presence of insulin 
or Cu. (C) Novel consensus DNA-binding motifs identified within MTF1 peaks. Shown are 
MRE and the top five most significant motifs enriched, including the DNA logo, its 
corresponding TF, and its p-value. (D) Genome browser tracks of replicate ChIP-Seq 
experiments examining MTF1 binding to the Myogenin promoter in differentiating myoblasts 
(24 h) under different culture conditions. (E) ChIP-qPCR validation for MTF1 binding to the 
Myogenin promoter. Data represent the average of three independent biological replicates ± 
SE; *P < 0.01. 
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Figure 5 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. MTF1 interacts with MyoD at the promoter regions of myogenic genes. 
Representative Western blot of MTF1-MyoD immunoprecipitation (IP). Pulldown with IgG 
was used as a negative control. (B) Overlap of MTF1 ChIP-seq peaks from primary 
myoblasts differentiated with Cu MTF1 and MyoD peaks extracted from datasets published 
by Solemaini et al., 2012 (GSE24852). (C) Consensus binding motifs identified for sequences 
bound by MTF1 and MyoD. Shown are the top five most significant motifs enriched, 
including the DNA logo, its corresponding TF, and its p-value. (D) Genome browser tracks 
of ChIP-seq data comparing MTF1 occupancy at the myogenin locus in cells 24 h after 
differentiation with Cu and MyoD occupancy at the myogenin locus in proliferating (GM) 
cells or cells differentiated for 10 or 48 hours. MyoD ChIP-seq data was downloaded and 
analyzed from GSE24852 (Soleimani et al., 2012) [106]. (E-F) Reciprocal chromatin 
immunoprecipitation (Re-ChIP)-qPCR for MTF1-MyoD co-binding to the Myogenin 
promoter (E) and to the Pax7 promoter (F) as a negative control. Data represent the average 
of three independent biological replicates ± SE; *P < 0.01. 
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Figure 6 
 
 
 
 
 
 
Figure 6. MTF1 binds Cu, which correlates with nuclear translocation of the metal. (A) 
Upper panel depicts the sequence containing the tetra-cysteine cluster at the carboxy-terminal 
of the murine MTF1 that is required for transcriptional response to Zn and Cd (amino acids 
632, 634, 636 and 638) [86]. These residues were mutated to Alanine to asses Cu-binding 
capabilities of this putative metal-binding site (MBS). Lower panel shows a representative 
Coomassie Brilliant Blue-stained SDS/PAGE and a Western blot immunostained with anti-
MTF1. (B) Cu binding stoichiometry of purified wild type and MTF mutated at the Cu-
binding site (MBS) determined by AAS.  (C) Whole cell Cu content of proliferating and 
differentiating primary myoblasts determined by AAS. Nuclear (D) and cytosolic (E) Cu 
content of proliferating and differentiating primary myoblasts cultured under different Cu 
conditions. Metal determination was performed by AAS. Data represent the mean Cu 
concentration of three independent biological replicates ± SE.  
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